Display options
Cite
St Helen G, Liakoni E, Nardone N, et al. Comparison of Systemic Exposure to Toxic and/or Carcinogenic Volatile Organic Compounds (VOC) during Vaping, Smoking, and Abstention. Cancer Prev Res (Phila). 2019;13(2):153-162doi: 10.1158/1940-6207.CAPR-19-0356.
St Helen, G., Liakoni, E., Nardone, N., Addo, N., Jacob, P., & Benowitz, N. L. (2020). Comparison of Systemic Exposure to Toxic and/or Carcinogenic Volatile Organic Compounds (VOC) during Vaping, Smoking, and Abstention. Cancer prevention research (Philadelphia, Pa.), 13(2), 153-162. https://doi.org/10.1158/1940-6207.CAPR-19-0356
St Helen, Gideon, et al. "Comparison of Systemic Exposure to Toxic and/or Carcinogenic Volatile Organic Compounds (VOC) during Vaping, Smoking, and Abstention." Cancer prevention research (Philadelphia, Pa.) vol. 13,2 (2020): 153-162. doi: https://doi.org/10.1158/1940-6207.CAPR-19-0356
St Helen G, Liakoni E, Nardone N, Addo N, Jacob P, Benowitz NL. Comparison of Systemic Exposure to Toxic and/or Carcinogenic Volatile Organic Compounds (VOC) during Vaping, Smoking, and Abstention. Cancer Prev Res (Phila). 2020 Feb;13(2):153-162. doi: 10.1158/1940-6207.CAPR-19-0356. Epub 2019 Sep 25. PMID: 31554628; PMCID: PMC7007368.
Copy Download .nbib Format: NLM
Share it on

Cancer Prev Res (Phila). 2020 Feb;13(2):153-162. doi: 10.1158/1940-6207.CAPR-19-0356. Epub 2019 Sep 25.

Comparison of Systemic Exposure to Toxic and/or Carcinogenic Volatile Organic Compounds (VOC) during Vaping, Smoking, and Abstention.

Cancer prevention research (Philadelphia, Pa.)

Gideon St Helen, Evangelia Liakoni, Natalie Nardone, Newton Addo, Peyton Jacob, Neal L Benowitz

Affiliations

  1. Clinical Pharmacology Research Program, Division of Cardiology, Zuckerberg San Francisco General Hospital, Department of Medicine, University of California, San Francisco, California. [email protected].
  2. Center for Tobacco Control Research and Education (CTCRE), University of California, San Francisco, California.
  3. Clinical Pharmacology and Toxicology, Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  4. Clinical Pharmacology Research Program, Division of Cardiology, Zuckerberg San Francisco General Hospital, Department of Medicine, University of California, San Francisco, California.
  5. Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, California.

PMID: 31554628 PMCID: PMC7007368 DOI: 10.1158/1940-6207.CAPR-19-0356

Abstract

Comparisons of systemic exposure to toxicants during monitored cigarette smoking, electronic cigarette (e-cigarette) use, and abstention are needed to enhance our understanding of the risks of e-cigarette use (vaping). In a cross-over study, we measured 10 mercapturic acid metabolites of volatile organic compounds (VOCs) in 24-hour urine samples collected from 36 dual users (8 women) of e-cigarettes and cigarettes during 2 days of

©2019 American Association for Cancer Research.

References

  1. Chem Res Toxicol. 2012 Apr 16;25(4):794-810 - PubMed
  2. Chem Res Toxicol. 2009 Apr;22(4):734-41 - PubMed
  3. Tob Control. 2003 Dec;12(4):424-30 - PubMed
  4. Ann Intern Med. 2017 Mar 21;166(6):390-400 - PubMed
  5. AAPS PharmSciTech. 2009;10(2):317-28 - PubMed
  6. Cancer Epidemiol Biomarkers Prev. 2013 May;22(5):765-72 - PubMed
  7. ACS Omega. 2017 Mar 31;2(3):1207-1214 - PubMed
  8. Mol Nutr Food Res. 2011 Sep;55(9):1277-90 - PubMed
  9. Addiction. 2019 Dec 14;:null - PubMed
  10. Am J Physiol Lung Cell Mol Physiol. 2015 Jul 15;309(2):L175-87 - PubMed
  11. Addiction. 2019 Nov 6;:null - PubMed
  12. Lancet. 2003 Feb 1;361(9355):361-2 - PubMed
  13. Br J Ind Med. 1993 May;50(5):460-9 - PubMed
  14. Environ Sci Technol. 2016 Sep 6;50(17):9644-51 - PubMed
  15. JAMA Netw Open. 2018 Dec 7;1(8):e185937 - PubMed
  16. Pediatrics. 2018 Apr;141(4): - PubMed
  17. Sci Rep. 2018 Jan 11;8(1):507 - PubMed
  18. BMC Public Health. 2016 Jul 11;16:543 - PubMed
  19. J Phys Chem A. 2012 May 10;116(18):4602-9 - PubMed
  20. N Engl J Med. 2017 Sep 21;377(12):1111-1114 - PubMed
  21. IARC Sci Publ. 1988;(85):3-18 - PubMed
  22. Chem Commun (Camb). 2009 Jul 14;(26):3934-6 - PubMed
  23. J Expo Sci Environ Epidemiol. 2019 Aug 12;:null - PubMed
  24. Anal Bioanal Chem. 2017 Feb;409(5):1247-1256 - PubMed
  25. Nicotine Tob Res. 2019 Aug 19;21(9):1228-1238 - PubMed
  26. Mol Nutr Food Res. 2012 Dec;56(12):1825-37 - PubMed
  27. N Engl J Med. 2010 Jun 17;362(24):2295-303 - PubMed
  28. Nicotine Tob Res. 2018 Jan 5;20(2):206-214 - PubMed
  29. Nicotine Tob Res. 2017 Feb;19(2):160-167 - PubMed
  30. PLoS One. 2017 Mar 8;12(3):e0173055 - PubMed
  31. Am J Physiol Lung Cell Mol Physiol. 2019 Jan 1;316(1):L94-L104 - PubMed
  32. Nicotine Tob Res. 2017 Oct 1;19(10):1224-1231 - PubMed
  33. Tob Control. 2017 Mar;26(e1):e23-e28 - PubMed
  34. Food Chem Toxicol. 2001 Feb;39(2):183-205 - PubMed
  35. Br J Ind Med. 1987 Dec;44(12):834-40 - PubMed
  36. Regul Toxicol Pharmacol. 2016 Nov 15;81 Suppl 1:S1-S14 - PubMed
  37. Aerosol Sci Technol. 2018;52(11):1219-1232 - PubMed
  38. J Agric Food Chem. 2003 Jan 29;51(3):802-8 - PubMed

Substances

MeSH terms

Publication Types

Grant support